Strategies to Improve Adverse Drug Reaction Reporting: A Critical and Systematic Review

Drug Safety ◽  
2013 ◽  
Vol 36 (5) ◽  
pp. 317-328 ◽  
Author(s):  
Cristian Gonzalez-Gonzalez ◽  
Elena Lopez-Gonzalez ◽  
Maria T. Herdeiro ◽  
Adolfo Figueiras
2021 ◽  
Vol 2021 ◽  
pp. 1-12
Author(s):  
Tahmine Salehi ◽  
Naiemeh Seyedfatemi ◽  
Mohammad Saeed Mirzaee ◽  
Maryam Maleki ◽  
Abbas Mardani

Aim. To describe and synthesize aspects of knowledge, attitudes, and practice regarding pharmacovigilance and adverse drug reaction (ADR) reporting and to explore associated barriers from a nurse perspective. Methods. A systematic review was conducted. Electronic databases including MEDLINE, Embase, Scopus, and Web of Knowledge from January 2010 to October 2020 were searched. Original observational studies that were written in English and which focused on nurses’ knowledge, attitudes, practice, and perceived barriers regarding pharmacovigilance and ADR reporting in various healthcare settings were included. Results. Twenty-three studies published in English from 2010 to 2020 were retrieved during the search process. Overall, in the knowledge domain, the median percentages of nurses who were aware of the definitions of ADRs were 74.1%, while only 26.3% were aware of the adverse drug reaction reporting form. In the attitude domain, 84.6% of nurses believed ADR reporting to be important for patient/medicine safety and 37.1% had a fear of legal liability following ADR reporting. Although 67.1% of nurses encountered ADRs during their professional life, only 21.2% had a history of ADR reporting. In addition, lack of knowledge/training (median: 47.1%) was identified as the most common barrier in ADR reporting from a nursing viewpoint. Conclusion. Despite positive nurse attitudes, knowledge and practice in relation to pharmacovigilance activities and ADR reporting did not occur regularly or often. Improving nurses’ knowledge through in-service training and degree-level education and addressing the main barriers of ADR reporting may help to achieve an improved level of reporting.


Author(s):  
Zuzaan Zulzaga ◽  
Erdenetuya Myagmarsuren ◽  
Herman J. Woerdenbag ◽  
Eugene P. van Puijenbroek

AbstractMonitoring adverse drug reactions is a vital issue to ensure drug safety and to protect the general public from medication-related harmful effects. In order to properly monitor drug safety, a regulatory system needs to be in place as well as an infrastructure that allows for analyzing national and international safety data. In Mongolia, adverse drug reaction (ADR) reporting activities have been implemented in the past decade. During this period, the basic structure and legal basis of an adverse drug reaction monitoring system was established. Because of the fragmented but growing healthcare system and the complexity of pharmaceutical issues in Mongolia, a sustainable process for the development of the adverse drug reaction reporting system is a key issue. The aim of this article is to disclose the Mongolian situation for the rest of the world and to share experiences on how an ADR reporting system can be developed towards a higher and more advanced level to contribute to both national and international drug safety issues. In this article, we review the features of the Mongolian health care and pharmaceutical systems, as well as the current development of the adverse drug reaction reporting system.


1989 ◽  
Vol 138 (1) ◽  
pp. 516-519 ◽  
Author(s):  
Michael D Rawlins ◽  
Alasdair M Breckenridge ◽  
Susan M Wood

2014 ◽  
Vol 9 (1) ◽  
pp. 49-55 ◽  
Author(s):  
Aikaterini Toska ◽  
Geitona Mary ◽  
Souliotis Kyriakos ◽  
Saridi Maria ◽  
Demetzos Costas

Sign in / Sign up

Export Citation Format

Share Document